Vital expertise in virotherapy manufacturing

Specializing in live viruses and viral vectors─ we enable our customers in the development and manufacture of transformational oncolytic virus, gene therapy, and vaccine products to advance human health.

Read more about us


Since 2002, we have supported global clientele across clinical and regulatory arenas with comprehensive CDMO services

ABOUT US: High quality, efficiency, and scientific expertise define our service.

Learn more

FACILITIES: US and EU locations provide flexibility and security of supply.

Explore our facilities


From starting material generation to full drug substance and product capabilities

Vibalogics can assist you through a comprehensive service portfolio – ensuring the success of your virotherapy, beginning with process development and technical transfer feasibility, through cGMP production and validation.

What makes us the best choice

A “Pure-Play” Virotherapy CDMO

20 years focused on delivering virotherapy services with over $200M in active investment.

Virotherapy Expertise

Critical guidance and technical oversight enable our customers development of robust products and processes for clinical- and commercial-use.

End-to-End Services

Complete offerings from GMP cell & viral banking, process and analytical development, GMP drug substance and drug product fill & finish.

Capacity & Quality

BSL-2 facilities and continues reinvestment provide capacity-rich infrastructure with quality compliance to international GMP standards.

Meet our leadership & scientific advisory

Deep Dive

GMP Manufacturing of Oncolytic Viruses: Critical Steps and Key Considerations

In our latest edition of Virotherapy Insider: Deep Dive, we will discuss the critical steps involved in OV development, manufacturing, testing, and explore the measures that need to be taken at each stage to ensure success.